Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery

NCT02573610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

576

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract Surgery

Interventions

DRUG: DE-108
DRUG: Levofloxacin 0.5%

Sponsor

Santen Pharmaceutical Co., Ltd.